Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Protecting Your Portfolio From an Election Surprise
00:47 - Kristina Hooper, U.S. investment strategist at Allianz, discusses an investment strategy to protect your portfolio from a potential political surprise on Election Day. She speaks on "Bloomberg Daybreak: Americas." (Source: Bloomberg)
  • Investing in U.K.’s Female Entrepreneurs
  • T-Mobile Builds Subscribers as AT&T Targets Content
  • British Banks Edge Closer to Post-Brexit Exit